ArticleJournal of translational medicine2026

Chelerythrine: a novel candidate for targeting miR-21/PTEN/PI3K/AKT in nasopharyngeal carcinoma.

Wenqing Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.